Heterogeneity in genetic susceptibility to prostate cancer

European Journal of Internal Medicine

Volumn 12, Issue 1, 2001, Pages 11-16

  Cussenot, O ^a,b   Valeri, A ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT UNIVERSITAIRE DE FRANCE   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Ethnic differences; Familial aggregation; Genetic predisposition; Hereditary prostate cancer; Prostate cancer risk

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; SEX HORMONE; SOMATOMEDIN C; VITAMIN D RECEPTOR;

ALLELE; CANCER INCIDENCE; CANCER RISK; CHROMOSOME 1; ETHNIC DIFFERENCE; FAMILIAL CANCER; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; PROSTATE CANCER; REVIEW; RISK FACTOR;

EID: 0035143613     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(00)00136-9     Document Type: Review

References (40)

1. Studies of genetic factors in prostate cancer in twin populations
2. Hereditary prostate cancer: epidemiologic and clinical features
3. Mendelian inheritance of familial prostate cancer
4. Evidence for autosomal dominant inheritance of prostate cancer
5. Segregation analysis of prostate cancer in Sweden: support for dominant inheritance
6. Evidence of an X-linked or recessive genetic component to prostate cancer risk
7. The impact of family history on early detection of prostate cancer (Letter)
8. Etude PROGENE, projet français d'analyse génétique du cancer de la prostate familial: recrutement et analyse
9. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search
10. Early age at diagnosis in families provide evidence of linkage to the Hereditary Prostate Cancer 1 (HPC1) locus on chromosome1
11. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer susceptibility gene at 1q24-25
12. Linkage analysis of chromosome 1q markers in 136 prostate cancer families
13. Predisposing gene for early onset prostate cancer localised on chromosome 1 q 42.2-43
14. Linkage analysis of 150 high-risk prostate cancer families at 1q24-25
15. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study
16. Re: prostate cancer susceptibility locus on chromosome 1q: a confirmatory study [comment]
17. Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees
18. Combined analysis of hereditary prostate cancer linkage to 1q 24-25: results from 772 hereditary prostate cancer families form the International Consortium for Prostate Cancer Genetics
19. No evidence of linkage for chromosome 1q42.2-43 in prostate cancer
20. Analysis of chromosome 1q 42.2-43 in 152 families with high risk of prostate cancer
21. Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer
22. Evidence for a prostate cancer-susceptibility locus on chromosome 20
23. Evidence for a prostate cancer susceptibility locus on the X chromosome
24. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX
25. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36
26. Risk of prostate, ovarian and endometrial cancer among relatives of women with breast cancer
27. Early onset and familial predisposition to prostate cancer significantly enhance the probability of breast cancer in first degree relatives
28. Loss of heterozygosity of BRCA1 and other loci on chromosome 17q in human prostate cancer
29. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13
30. 5α-Reductase activity and risk of prostate cancer among japanese and white and black males
31. Unusual length polymorphism in human steroid 5α-reductase type 2 gene (SRD5A2)
32. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility
33. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)
34. Modification of clinical presentation of prostate tumors by a novel genetic variant in CY3A4
35. Microsatellite mutation (CAG (24-to-18)) in the androgen receptor gene in human prostate cancer
36. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups
37. The CAG and GGC microsatellites of the androgen receptor gene are linkage disequilibrium in men with prostate cancer
38. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population
39. Vitamin D receptor polymorphisms as markers in prostate cancer